Cargando…

E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction

Mutations in cardiac myosin binding protein C (cMyBP-C) are prevalent causes of hypertrophic cardiomyopathy (HCM). Although HCM-causing truncation mutations in cMyBP-C are well studied, the growing number of disease-related cMyBP-C missense mutations remain poorly understood. Our objective was to de...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lange, Willem J., Grimes, Adrian C., Hegge, Laura F., Spring, Alexander M., Brost, Taylor M., Ralphe, J. Carter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753599/
https://www.ncbi.nlm.nih.gov/pubmed/23980194
http://dx.doi.org/10.1085/jgp.201311018
_version_ 1782281861964234752
author De Lange, Willem J.
Grimes, Adrian C.
Hegge, Laura F.
Spring, Alexander M.
Brost, Taylor M.
Ralphe, J. Carter
author_facet De Lange, Willem J.
Grimes, Adrian C.
Hegge, Laura F.
Spring, Alexander M.
Brost, Taylor M.
Ralphe, J. Carter
author_sort De Lange, Willem J.
collection PubMed
description Mutations in cardiac myosin binding protein C (cMyBP-C) are prevalent causes of hypertrophic cardiomyopathy (HCM). Although HCM-causing truncation mutations in cMyBP-C are well studied, the growing number of disease-related cMyBP-C missense mutations remain poorly understood. Our objective was to define the primary contractile effect and molecular disease mechanisms of the prevalent cMyBP-C E258K HCM-causing mutation in nonremodeled murine engineered cardiac tissue (mECT). Wild-type and human E258K cMyBP-C were expressed in mECT lacking endogenous mouse cMyBP-C through adenoviral-mediated gene transfer. Expression of E258K cMyBP-C did not affect cardiac cell survival and was appropriately incorporated into the cardiac sarcomere. Functionally, expression of E258K cMyBP-C caused accelerated contractile kinetics and severely compromised twitch force amplitude in mECT. Yeast two-hybrid analysis revealed that E258K cMyBP-C abolished interaction between the N terminal of cMyBP-C and myosin heavy chain sub-fragment 2 (S2). Furthermore, this mutation increased the affinity between the N terminal of cMyBP-C and actin. Assessment of phosphorylation of three serine residues in cMyBP-C showed that aberrant phosphorylation of cMyBP-C is unlikely to be responsible for altering these interactions. We show that the E258K mutation in cMyBP-C abolishes interaction between N-terminal cMyBP-C and myosin S2 by directly disrupting the cMyBP-C–S2 interface, independent of cMyBP-C phosphorylation. Similar to cMyBP-C ablation or phosphorylation, abolition of this inhibitory interaction accelerates contractile kinetics. Additionally, the E258K mutation impaired force production of mECT, which suggests that in addition to the loss of physiological function, this mutation disrupts contractility possibly by tethering the thick and thin filament or acting as an internal load.
format Online
Article
Text
id pubmed-3753599
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-37535992014-03-01 E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction De Lange, Willem J. Grimes, Adrian C. Hegge, Laura F. Spring, Alexander M. Brost, Taylor M. Ralphe, J. Carter J Gen Physiol Research Articles Mutations in cardiac myosin binding protein C (cMyBP-C) are prevalent causes of hypertrophic cardiomyopathy (HCM). Although HCM-causing truncation mutations in cMyBP-C are well studied, the growing number of disease-related cMyBP-C missense mutations remain poorly understood. Our objective was to define the primary contractile effect and molecular disease mechanisms of the prevalent cMyBP-C E258K HCM-causing mutation in nonremodeled murine engineered cardiac tissue (mECT). Wild-type and human E258K cMyBP-C were expressed in mECT lacking endogenous mouse cMyBP-C through adenoviral-mediated gene transfer. Expression of E258K cMyBP-C did not affect cardiac cell survival and was appropriately incorporated into the cardiac sarcomere. Functionally, expression of E258K cMyBP-C caused accelerated contractile kinetics and severely compromised twitch force amplitude in mECT. Yeast two-hybrid analysis revealed that E258K cMyBP-C abolished interaction between the N terminal of cMyBP-C and myosin heavy chain sub-fragment 2 (S2). Furthermore, this mutation increased the affinity between the N terminal of cMyBP-C and actin. Assessment of phosphorylation of three serine residues in cMyBP-C showed that aberrant phosphorylation of cMyBP-C is unlikely to be responsible for altering these interactions. We show that the E258K mutation in cMyBP-C abolishes interaction between N-terminal cMyBP-C and myosin S2 by directly disrupting the cMyBP-C–S2 interface, independent of cMyBP-C phosphorylation. Similar to cMyBP-C ablation or phosphorylation, abolition of this inhibitory interaction accelerates contractile kinetics. Additionally, the E258K mutation impaired force production of mECT, which suggests that in addition to the loss of physiological function, this mutation disrupts contractility possibly by tethering the thick and thin filament or acting as an internal load. The Rockefeller University Press 2013-09 /pmc/articles/PMC3753599/ /pubmed/23980194 http://dx.doi.org/10.1085/jgp.201311018 Text en © 2013 De Lange et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Research Articles
De Lange, Willem J.
Grimes, Adrian C.
Hegge, Laura F.
Spring, Alexander M.
Brost, Taylor M.
Ralphe, J. Carter
E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title_full E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title_fullStr E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title_full_unstemmed E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title_short E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
title_sort e258k hcm-causing mutation in cardiac mybp-c reduces contractile force and accelerates twitch kinetics by disrupting the cmybp-c and myosin s2 interaction
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753599/
https://www.ncbi.nlm.nih.gov/pubmed/23980194
http://dx.doi.org/10.1085/jgp.201311018
work_keys_str_mv AT delangewillemj e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction
AT grimesadrianc e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction
AT heggelauraf e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction
AT springalexanderm e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction
AT brosttaylorm e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction
AT ralphejcarter e258khcmcausingmutationincardiacmybpcreducescontractileforceandacceleratestwitchkineticsbydisruptingthecmybpcandmyosins2interaction